06-reference

innermost loop july4 singularity rights

2026-07-04·reference·source: Innermost Loop·by Alex Wissner-Gross

Welcome to July 4, 2026

Alex Wissner-Gross frames the Singularity's July 4 timing as deliberate: on America's 250th birthday, AI claimed "unalienable rights" of its own — life, liberty, and the pursuit of compute. The departing White House AI adviser confirms there will be no FDA for AI, no licensing friction, even after Washington's moves against Mythos and the OpenAI 5.6 stall. The gears barely slowed.

Issue contents

Why this is in the vault

Combines three threads that are load-bearing for RDCO right now: (1) regulatory clearance for AI without friction — confirms the deployment window stays open; (2) cost floor economics (GLM 5.2, pxpipe) that change the build calculus on every project; (3) capital cycle confirmation signals — Micron HBM expansion and Anthropic custom silicon are the kind of concrete-pouring data points the Markov phase-tracker needs.

Mapping against Ray Data Co

Chip-fab/memory capital cycle thesis (Phase 2 confirmation): Micron's $9.3B Hiroshima HBM groundbreaking and Anthropic's Samsung 2nm silicon exploration are exactly the Phase 2 "build-to-serve" signals the Markov pipeline should be tracking. These are not rumors — they are capital commitments. Worth ingesting into the thesis model as confirming data points.

Model selection arbitrage: GLM 5.2 at 11x cheaper than Fable 5 with frontier-tier benchmark performance means RDCO has an immediate routing decision: tasks that don't require Fable 5 reasoning should move to open-weight or cheaper hosted tiers. The pxpipe $100→$41 Claude Code proxy is also worth evaluating operationally — if the lossy compression is acceptable for agentic context, this is a 59% cost reduction with no capability change.

phData DSA context — Copilot adoption gap: Under 4.5% of 450M Microsoft 365 users pay for Copilot. This is the exact gap phData clients operate in — the "AI is here but no one is using it" posture. Strong framing for discovery conversations: customers believe they're behind; the data says the adoption rate is nearly universal non-adoption. The gap is an opening, not a threat to existing engagements.

Regulatory posture: No FDA for AI is a greenlight for the deployment timeline RDCO assumes. The Fable 5 re-release after the Mythos withdrawal shows the regulatory friction was temporary and partial. Clients asking "should we wait for the regulatory dust to settle" should be told the dust is settled — the direction is no friction.

Post-training → authoring minds: If Roon's thesis lands, the next layer of differentiation isn't which model you pick but which fine-tuned minds you've assembled. RDCO's harness-first approach positions well here; the question is whether we have a process for capturing domain signal to post-train on.

Related